Home
The Hemopurifier®
The Hemopurifier® in Infectious Disease
The Hemopurifier® in Cancer
Resources
About
Overview
Executive Team
Board of Directors
Contact Us
News & Media
Press Releases
Presentations
Events
Outside Media
Training Videos
Investors
Overview
Corporate News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
IRS Form 8937
Clinical Trials
Depleting Exosomes to Improve Response to Immune Therapy in Head and Neck Squamous Cell Cancer: An Early Feasibility Phase I Clinical Trial
Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans with Hemopurifier
®
Device (TBA)